正在加载视频...

视频加载失败

Hayek on Marxism vs economic reality: “Marxists can never understand the functioning of the market. They believe it’s the costs which determine prices.” “The truth is exactly the opposite: it’s prices which tell people how much cost they ought to involve. It is prices by which the knowledge of...

101,501 次观看 • 2 个月前 •via X (Twitter)

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

Marc Andreessen: “I’m always urging founders to raise prices, raise prices, raise prices.” “We spend a lot of time working with our companies on pricing,” a16z co-founder Marc Andreessen explains. “It’s really this magical art and science that a lot of companies don’t take seriously enough.” Marc continues: “A core principle of pricing is that you don’t want to price by cost if you can avoid it. You want to price by value. Especially when you’re selling to businesses, you want to price as a percentage of the business value you’re creating.” He gives the example of building an AI that can do the job of a programmer, a lawyer, or a radiologist: “Can you price by value and get a percentage of what otherwise would’ve literally been a person? Or equivalently can you price by marginal productivity? If you can take a human doctor and make them much more productive because you give them AI, can you price as a percentage of the productivity uplift?” Marc argues that high prices are under-appreciated by founders: “The naive view on pricing is the lower the pricing, the better it is for the customer. The more sophisticated way of looking at it is that higher prices are often good for the customer because the higher price means the vendor can make the product better, faster. Companies with higher prices and higher margins can actually invest more in R&D and make the product better. Most people who buy things aren’t just looking for the cheapest price. They want something that’s going to work really well.” Marc also emphasizes this point in an interview in Elad Gil’s High Growth Handbook: “What I hear from companies is, ‘Oh, we have an awesome moat, and we’re still going to price our product cheap, because we think that’s somehow going to maximize our business.’ I’m always urging founders to raise prices, raise prices, raise prices. I’m always urging founders to raise prices, raise prices, raise prices. First of all, raising prices is a great way to flesh out whether you actually do have a moat. If you do have a moat, the customers will still buy, because they have to. The definition of a moat is the ability to charge more. And so number one, it’s just a good way to flesh out that topic and really expose it to sunlight. And then number two, companies that charge more can better fund both their distribution efforts and their ongoing R&D efforts. Charging more is a key lever to be able to grow. And the companies that charge more therefore tend to grow faster. That’s counterintuitive to a lot of engineers. A lot of engineers think there’s a one-dimensional relationship between price and value. They have this mental model of commerce like they’re selling rice or something. It’s like, “My product is magical and nobody can replicate it, and I need to price it like it’s a commodity.” No, you don’t. In fact, quite the opposite. If you price it high, then you can fund a much more expensive sales and marketing effort, which means you’re much more likely to win the market, which means you’re much more likely to be able afford to do all the R&D and acquisitions you’re going to want to do. And so we always try to snap people into a two-dimensional mindset, where higher prices equals faster growth.” Video source: a16z (2026)

Startup Archive

422,481 次观看 • 5 个月前

Friedberg: Two Reasons Why Drug Prices are So Expensive in America 📈 🫰 1) Government intervention in the market 🏢 "The way that we negotiate drug prices is pretty messed up." "As is the case with the cost of education and the cost of housing, the cost of drugs is largely inflated because of the federal government's role in being the primary buyer or capital provider to that market." "Through our purchases of prescription drugs, the federal government, as a buyer, doesn't have any incentive to keep prices low." " If every individual had to pay for their drugs, or private insurance was the only way to get your drugs, we would have a much more dynamic marketplace." 2) PBMs marking up prices 📈 "There's also this construct in the market, these PBMs or pharmacy benefit managers." "If they got cut out of the market, it would save a lot." "There's three major PBMs, CVS Caremark, Express Scripts, and Optum RX. They make money in markups." "The FTC has been investigating them and have several open cases." "Between 2017 and 2022, the estimate is that these companies generated $7.3B in excess profit by marking up prices on specialty generic drugs." "So as an intermediary, they provide this role where they can coordinate between the health insurer, the pharmacy which dispenses the drugs, and the drug manufacturers." Chamath: " But they're allowed to be owned by the payer, which is crazy." Friedberg: " And now they're allowed to be owned by the payer." "And there's a lot of obfuscation of the true cost of the drugs. There's a lot of markups, a lot of spread taking." "And so if you took the PBMs out of the market, that would solve one of the problems." " But at the end of the day, anytime the federal government is involved as a payer in any market-based system, it creates a distortion and the market is no longer free or efficient." david friedberg

The All-In Podcast

45,353 次观看 • 1 年前